
Quidel Corporation QDEL
$ 27.24
-0.62%
Quidel Corporation Book Value 2011-2026 | QDEL
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Quidel Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 11.9 B | 11.9 B | 10.8 B | 9.54 B | -3.43 B | -6.58 B | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 B | -6.58 B | 5.7 B |
Book Value of other stocks in the Diagnostics research industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
77.2 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
141 M | - | -17.87 % | $ 25.9 M | ||
|
Anixa Biosciences
ANIX
|
14 M | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Aspira Women's Health
AWH
|
6.73 M | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
75.7 M | $ 23.35 | -2.91 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
1.85 B | $ 34.5 | 2.16 % | $ 371 M | ||
|
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
35.4 M | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
16.7 M | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
86 M | - | - | $ 79.8 M | ||
|
Castle Biosciences
CSTL
|
456 M | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Danaher Corporation
DHR
|
77.5 B | $ 219.29 | -0.08 % | $ 160 B | ||
|
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
132 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
548 M | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.32 B | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
2.07 B | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
261 M | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
Celcuity
CELC
|
116 M | $ 109.48 | -2.35 % | $ 4.32 B | ||
|
Exact Sciences Corporation
EXAS
|
2.4 B | $ 102.41 | 0.1 % | $ 19 B | ||
|
DarioHealth Corp.
DRIO
|
96.4 M | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
1.13 B | $ 26.19 | -0.19 % | $ 792 M | ||
|
Guardant Health
GH
|
-140 M | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | ||
|
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | ||
|
IDEXX Laboratories
IDXX
|
1.6 B | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Illumina
ILMN
|
6.3 B | $ 144.81 | -3.26 % | $ 23 B | ||
|
QIAGEN N.V.
QGEN
|
6.15 B | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
6.07 B | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
3.51 B | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Lantheus Holdings
LNTH
|
1.09 B | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Quest Diagnostics Incorporated
DGX
|
16.2 B | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Biodesix
BDSX
|
20.9 M | $ 10.11 | 4.66 % | $ 1.31 B | ||
|
Precipio
PRPO
|
14.4 M | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
8.07 B | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
ICON Public Limited Company
ICLR
|
9.52 B | $ 181.44 | -2.39 % | $ 15 B | ||
|
Medpace Holdings
MEDP
|
826 M | $ 582.66 | -1.76 % | $ 18 B | ||
|
Koninklijke Philips N.V.
PHG
|
12 B | $ 28.66 | -2.02 % | $ 20 B | ||
|
Agilent Technologies
A
|
5.39 B | $ 133.33 | 0.07 % | $ 40.5 B | ||
|
Biomerica
BMRA
|
4.1 M | $ 2.41 | 0.84 % | $ 5.54 M | ||
|
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | ||
|
Bioventus
BVS
|
221 M | $ 7.86 | 0.51 % | $ 492 M | ||
|
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K |